Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 in the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:20:07.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Recent history entries show Study Status updates on 2025-12-22 and 2025-12-23. A deletion entry dated 2025-05-02 appears in the version history for NCT05297890.
    Difference
    0.4%
    Check dated 2025-12-30T10:17:08.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added an entry 'Revision: v3.3.3' to the Record History and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T09:42:15.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new system revision entry v3.3.2 was added to the history, replacing the earlier v3.3.1 entry. This is a release-note level update and does not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:51:42.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added to the record history, and the previous revision v3.2.0 was removed from the list.
    Difference
    0.1%
    Check dated 2025-11-24T13:27:43.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Deleted the temporary government funding notice about updates and inquiries during appropriation lapses, which previously warned that the site may be out of date and inquiries delayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:28:57.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.